Part 2: Featured interview with BioPharm International
Finding the right clinical trial for the right patient can be challenging, particularly when eligibility criteria depend on complex details found throughout the patient record.
In part two of ConcertAI’s four-part interview series with BioPharm International, Eron Kelly, CEO, and Shaalan Beg, MD, CMO of Oncology, discuss how AI can help physicians identify trial-eligible patients by extracting key information—including biomarker status, treatment history, and other clinical details—from unstructured data.
They also explore how these capabilities can help physicians look beyond traditional trial evidence and compare outcomes across similar real-world patient populations, providing additional context to inform treatment decisions.
Watch the interview to learn how ConcertAI is putting AI and clinical evidence to work at the point of care.